PCORI-CER-1306-03385 Lung Cancer Screening Decision Aid Development and Testing

Launched by M.D. ANDERSON CANCER CENTER · Nov 4, 2014

Keywords

ClinConnect Summary

This clinical trial, called PCORI-CER-1306-03385, is focused on helping heavy smokers understand their options for lung cancer screening using a type of scan called low-dose computed tomography (CT). The goal is to create and test a decision-making tool that reflects the latest guidelines about lung cancer screening. During this first phase, the researchers will update the tool based on current information and will test it with patients to see how well it works and if people find it helpful. They will also improve a questionnaire that measures knowledge about lung cancer to ensure it is accurate and reliable.

To be eligible for this study, participants must be between 55 and 80 years old, speak English, and either be current smokers or have quit within the last 15 years. People with a history of lung cancer cannot participate. If you join the trial, you can expect to provide feedback on the updated decision aid and the knowledge questionnaire, helping researchers understand how to better inform others about lung cancer screening. Your input will be valuable in shaping tools that aim to support smokers in making informed health decisions.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Men and women 55 to 80 years of age.
• • 2. Participants must speak English.
• • 3. Current smoker or quit smoking within the past 15 years.
• Exclusion Criteria:
• • 1. History of lung cancer.